期刊文献+

心脏超声技术在肥厚型梗阻性心肌病化学消融中的运用 被引量:3

Application of Echocardiography in Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
下载PDF
导出
摘要 肥厚型梗阻性心肌病化学消融术是近年来发展起来的一项治疗肥厚型心肌病的新技术,由于和开胸手术相比具有创伤小,效果相当,因此该技术在临床上的使用呈逐年增加的趋势。该术式成功的关键在于准确的定位及可控性的消融梗阻部分心肌,其中心脏超声技术在肥厚型梗阻性心肌病化学消融术的术前诊断、术后随访中扮演了重要角色,特别是超声心肌造影技术在化学消融术的术中监测中起到了更为重要的作用,现就心脏超声技术在肥厚型梗阻性化学消融术中的运用做一综述。 Alcohol septal ablation(ASA) has emerged as a minimally invasive modality for treatment of hypertrophic obstructive cardiomyopathy compared to surgical myomectomy.The procedure has been refined throughout the years.How to localize the area of myocardial target is the key point of success.The technology of echocardiography plays an important role in the diagnosis and follow-up of hypertrophic obstructive cardiomyopathy.As the development of echocardiography,especially the myocardial contrast echocardiography,which has became the standard monitor in the intraoperation of ASA.So we review the role of echocardiography in the procedure of ASA.
作者 罗端 罗俊
出处 《心血管病学进展》 CAS 2011年第6期901-903,共3页 Advances in Cardiovascular Diseases
关键词 肥厚型梗阻性心肌病化学消融术 心脏超声 心肌声学造影 alcohol septal ablation for hypertrophic obstructive cardiomyopathy echocardiography myocardial contrast echocardiography
  • 相关文献

参考文献11

  • 1Maron BJ,McKenna WJ,Danielson GK,et al.American College of Cardiology/European Society of Carliology clinical expert consensus document on hypertrophic cardiomyopathy.A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines[J].J Am Coll Cardiol,2003,42(9):1687-1713.
  • 2Maron BJ,Dearani JA,Ommen SR,et al.The case for surgery in obstructive hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2004,44(10):2044-2053.
  • 3Holmes DR Jr,Valeti US,Nishimura RA.Alcohol septal ablation for hypertrophic cardiomyopathy:indications and technique[J].Catheter Cardiovasc Interv,2005,66(3):375-389.
  • 4Nagueh SF.Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy[J].J Am Coll Cardiol,1998,32:225-229.
  • 5Faber L,Ziemssen P,Seggewiss H.Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring[J].J Am Soc Echocardiogr,2000,13(12):1074-1079.
  • 6Veselka J,Duchonova R,Prochazkova S,et al.The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy[J].Kardiol Pol,2 004,60(2):133-136.
  • 7Yoerger DM,Picard MH,Palacios IF,et al.Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy[J].Am J Cardiol,2006,97(10):1511-1514.
  • 8Angelini P.The "1 st septal unit" in hypertrophic obstructive cardiomyopathy:a newly recognized anatomo-functional entity,identified during recent alcohol septal ablation experience[J].Tex Heart Inst J,2007,34(3):336-346.
  • 9Henein MY,OSullivan CA,Ramzy IS,et al.Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy[J].J Am Coll Cardiol,1999,34(4):1117-1122.
  • 10Veselka J,Prochazkova S,Bolomova-Homolova I,et al.Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index:a midterm follow-up[J].Echocardiography,2005,22(2):105-109.

同被引文献24

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部